Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Growth hormone illegal for off-label anti-aging use


Because of 1988 and 1990 amendments to the Food, Drug and Cosmetic Act, off-label distribution or provision of human growth hormone to treat aging or age-associated illnesses is illegal in the United States, according to a report in the Journal of the American Medical Association.

The findings, which were peer-reviewed by independent experts and by the journal’s legal counsel, appear in the Oct. 26 issue.

A team of three noted health researchers revealed a largely unknown and unenforced law that thousands of entrepreneurs and physicians are breaking. The authors are Dr. Thomas Perls, director of the New England Centenarian Study at Boston Medical Center and associate professor of medicine at Boston University School of Medicine; Dr. Neal Reisman, clinical professor of plastic surgery at Baylor College of Medicine and associate chief of plastic surgery at St. Luke’s Episcopal Hospital, who is also an attorney; and S. Jay Olshansky, professor of epidemiology at the University of Illinois at Chicago School of Public Health.

Human growth hormone, or HGH, is a substance released by the pituitary gland that spurs growth and development in children and adolescents. As a drug, it can be prescribed legally only for three rare conditions: HGH deficiency-related syndromes that cause short stature in children, adult HGH deficiency due to rare pituitary tumors and their treatment, and muscle-wasting disease associated with HIV/AIDS. According to the U.S. Food and Drug Administration, any and all other uses of the drug, including the off-label use as an alleged treatment for aging and its related conditions, are illegal.

But many Web sites and anti-aging clinics market HGH with claims that the hormone stops and reverses aging and provides many other benefits, including improved nail and hair growth, better sleep, improved skin tone, better digestion, increased strength, weight loss, better eyesight and enhanced sexual function.

"Prescribing and administering HGH has become a routine intervention in an industry that is variably called anti-aging, regenerative, longevity or age management medicine," said Perls. "Hundreds of thousands of patients who have received HGH in recent years as a purported treatment for aging are unaware that they are receiving the drug illegally.

"Although there is no evidence that HGH administration stops or reverses aging, many people spend a great deal of money on these products," Perls said. "On the contrary, responsibly conducted and peer-reviewed science indicates that HGH could in fact accelerate aging and shorten lifespan. It is associated with very high rates of serious adverse effects, and long-term use could increase one’s risk of cancer."

According to Olshansky, "off-label use for many drugs is a normal and accepted practice in medicine, but that is not true for growth hormone. According to laws instituted by Congress more than 10 years ago, HGH can only be distributed for indications specifically authorized by the Secretary of Health and Human Services, and aging and its related disorders are not among them. The use of HGH as an alleged anti-aging intervention is a major public health concern not just because it is illegal, but also because its provision for anti-aging is not supported by science and it is potentially harmful."

Despite the fact that the vast majority of HGH prescriptions should be for children, 74 percent of HGH prescriptions in 2004 were for people 20 and older, and 44 percent were for people 40 to 59. Sales of HGH in 2004 totaled $622 million (almost 213,000 prescriptions) not including sales via anti-aging Web sites. "These data suggest that a very large proportion of HGH sales are for illegal uses," said Perls.

HGH is also distributed through the Internet, often at a high cost and in some cases without physician supervision, according to the researchers. Various forms of HGH -- ranging from pills to sprays to injectables -- are sold to consumers at a cost of $200 to $1,000 per month. One Web site alone was estimated by the Federal Trade Commission to have generated more than $70 million in sales of pills and sprays purported to contain HGH or to stimulate its production.

"Millions of dollars in profits are made off of useless pills and sprays like these," Perls said. "Pills with HGH are destroyed in the stomach, and because the molecule is too large to enter the blood stream via sublingual and nasal sprays, such products have absolutely no biological effect. You might as well be paying hundreds of dollars for sand and water."

"In 1988 and again in 1990, the [Food, Drug and Cosmetic Act] enacted very stringent controls with substantial penalties involving the distribution of HGH," said Reisman.

Despite the fact that HGH is not a Schedule III drug, like, for example, anabolic steroids, Congress specifically authorized the Drug Enforcement Agency to investigate offenses related to HGH distribution.

"Hopefully our paper will raise awareness of the legal issues surrounding the improper distribution, marketing, and provision of HGH and discourage this criminal practice," Reisman said.

Sherri McGinnis Gonzalez | EurekAlert!
Further information:

More articles from Studies and Analyses:

nachricht Diagnoses: When Are Several Opinions Better Than One?
19.07.2016 | Max-Planck-Institut für Bildungsforschung

nachricht High in calories and low in nutrients when adolescents share pictures of food online
07.04.2016 | University of Gothenburg

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>